IFCC Executive Board: 2012-2014 Biographies
Priv. - Doz. Doctor Thomas BRINKMANN , Corporate Representative
Sonic Healthcare
Mecklenburgische Strasse 28
14197 Berlin
Germany
E-mail: thomas.brinkmann@sonichealthcare.de
Thomas Brinkmann joined Sonic Healthcare in 2014 as CEO / Managing Director of the Labor Lademannbogen in Hamburg, Germany, and as Sonic Healthcare's Chief Scientific Officer, in Berlin, Germany.
Dr. Brinkmann graduated from the University of Bielefeld, Germany, and holds a PhD in Biochemistry from the same university. In 1991/92 he worked at the Pasteur Institute, Paris, France, and from 1992-2003 as assistant at the Institute of Laboratory and Transfusion Medicine of the Heart and Diabetes Centre Nordrhein-Westfalen in Bad Oeynhausen, a university hospital of the Ruhr-University Bochum, Germany. In this position he was senior assistant of the medical laboratory. He gained experience in clinical chemistry, immunodiagnostics, haematology, immunohaematology, microbiology, serology, blood banking and molecular biology.
He qualified as Clinical Chemist and since 1999 he has been registered as European Clinical Chemist (EurClinChem). Since 2001 he is associate professor for clinical biochemistry at the Medical Faculty of the Ruhr-University of Bochum, Germany.
In 2003 Dr. Brinkmann decided to continue his career in the industrial sector and joined Beckman Coulter's European headquarter in Nyon, Switzerland as head of the EMEAI Scientific Group. In this position, he directed a team of physicians and scientists in Europe, Middle East, Africa and India for scientific marketing, commercial support and lobbying. In 2011 Dr. Brinkmann joined Unilabs, a European diagnostic service provider, as Group Chief Medical Officer and as Medical Director of Unilabs' Swiss organisation.
Dr. Brinkmann has actively collaborated with many IFCC Committees and Working Groups and he served as the Corporate Representative on the IFCC Executive Board from 2009-2011.
With his experience in research and routine diagnostics in laboratory medicine, in scientific marketing of a global diagnostic company and in a commercial diagnostic organisation he will continue to serve in his second term as a link between IFCC and Diagnostic Industry.